Merck & Company, Inc. vs Insulet Corporation — Stock Comparison
Q·Score Breakdown
6.7
Neutral
Overall
7.8
Bullish
Quality
Health
Growth
Valuation
Sentiment
MRK
Forward P/E of 11.5× is low relative to sector peers.
PODD
Consensus analyst target of $326.35 is 86% above current price.
Analyst Consensus
BUY
Target $129.74 (+15.7%)
27 analysts
BUY
Target $326.35 (+86.4%)
23 analysts
Fundamentals
MRK
PODD
31.5×
Trailing P/E
50.3×
11.5×
Forward P/E
21.7×
13.6%
Profit Margin
9.1%
76.6%
Gross Margin
71.6%
—
ROE
18.1%
4.9%
Revenue Growth
31.2%
—
Earnings Growth
3.9%
0.28
Beta
1.47
—
Price / Book
—
$277.0B
Market Cap
$12.1B
$73 – $125
52-Week Range
$158 – $355
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →